Medicine Description piompride 30/4mg
piompride 30/4mg tablets is a medication that combines glimepiride and pioglitazone to manage type 2 diabetes mellitus effectively. Glimepiride, a sulfonylurea, enhances insulin release from the pancreas, thereby lowering blood glucose levels. It works by binding to specific receptors on pancreatic beta cells, stimulating insulin secretion. On the other hand, pioglitazone, a thiazolidinedione, enhances insulin sensitivity in peripheral tissues, particularly muscle and adipose tissue. It achieves this by activating peroxisome proliferator-activated receptor gamma (PPAR-γ), which regulates gene expression associated with glucose and lipid metabolism. The synergistic action of both components helps control blood glucose levels more effectively than either agent alone.
Indications and Uses of piompride 30/4mg tablets
- Management of type 2 diabetes mellitus in conjunction with diet and exercise.
- Improvement of glycemic control in patients who require both insulin secretagogues and insulin sensitizers.
Side Effects of piompride 30/4mg tablets
- Weight gain
- Hypoglycemia
- Edema
- Upper respiratory tract infections
- Gastrointestinal disturbances (nausea, vomiting, diarrhea)
Storage and Handling
Store piompride 30/4mg tablets in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use after the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should monitor their blood glucose levels regularly and adhere to prescribed lifestyle changes, including diet and exercise. It is essential to inform healthcare providers about any other medications being taken to avoid potential interactions. Patients should be aware of the signs of hypoglycemia and how to manage it effectively. Regular follow-ups with healthcare professionals are crucial for optimal diabetes management.